HIP DYSPLASIA, CONGENITAL
Clinical trials for HIP DYSPLASIA, CONGENITAL explained in plain language.
Never miss a new study
Get alerted when new HIP DYSPLASIA, CONGENITAL trials appear
Sign up with your email to follow new studies for HIP DYSPLASIA, CONGENITAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could babies with mild hip dysplasia skip the brace?
Disease control Recruiting nowThis study looks at whether simply monitoring babies with mild hip dysplasia is as good as using a brace. The brace, called a Pavlik harness, keeps the hips in proper position but can be hard on families. The trial will follow 514 infants under 3 months old across seven countries…
Matched conditions: HIP DYSPLASIA, CONGENITAL
Phase: NA • Sponsor: University of British Columbia • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New hip resurfacing device tracked for 10 years in 150 patients
Disease control Recruiting nowThis study follows 150 people aged 18 to 65 who receive the ROMAX hip resurfacing system to treat hip arthritis or dysplasia. Researchers will track how long the implant lasts and how well the hip functions over 10 years. The goal is to monitor the device's safety and performance…
Matched conditions: HIP DYSPLASIA, CONGENITAL
Sponsor: Medacta International SA • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC